P542 Infliximab salvage therapy in acute severe ulcerative colitis: A systematic review and meta-analysis
Matthew C. Choy(The University of Melbourne), Peter De Cruz(The University of Melbourne), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute), Talat Bessissow(Montreal General Hospital), Alex Al Khoury(McGill University Health Centre), David M. Faleck(Icahn School of Medicine at Mount Sinai), Alexander C. Ford(University of Leeds), Marla Dubinksy(Icahn School of Medicine at Mount Sinai), Dean Seah(Austin Hospital), Yoon‐Kyo An(Mater Hospital), Neville D. Yeomans(Royal Adelaide Hospital), Shailja C. Shah(San Francisco VA Medical Center)
Cited by 1
Related Papers
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
Chronic constipation
|Nature Reviews Disease Primers|2017|375
Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease
|Gastroenterology|2007|361
World Gastroenterology Organisation Global Guidelines
|Journal of Clinical Gastroenterology|2017|303